Clinical trials have an impact on the environment, and novel approaches may help researchers reshape their activities toward a greater sustainability
Updated results from the KEYNOTE-564 trial confirm the role of pembrolizumab after surgery
The tyrosine kinase inhibitor showed to prolong disease-free survival as compared to chemotherapy and clinically meaningful benefit with respect to CNS disease–free survival
In an interview, Prof. Julien Taieb comments on the major advances from colorectal cancer research which are driving the development of molecular-based therapies
Benefits of these targeted agents are not limited to tumours with germline BRCA1/2 mutations, but many questions remain to be answered
A study illustrates a methodology that shows promise to distinguish true negative liquid biopsy results from indeterminate results that may benefit from follow-up tissue testing
A nurse-led follow-up strategy including self-management interventions, use of patient-reported outcomes and phone consultations also resulted in lower fear of recurrence, anxiety and depression
In the last few years, study findings have changed clinical practice and offered new opportunities of care to many patients
A study reports high sensitivity and specificity of a cell-free DNA blood-based assay compared to colonoscopy
Universal health coverage in oncology is still not a reality, as a recent report shows
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.